A ‘mix and match’ approach to SARS-CoV-2 vaccination
A ‘mix and match’ approach to SARS-CoV-2 vaccination
About this item
Full title
A ‘mix and match’ approach to SARS-CoV-2 vaccination
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Nature medicine, 2021-09, Vol.27 (9), p.1510-1511
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Heterologous dosing with the adenovirus-based ChAdOx1 (AstraZeneca) vaccine followed by an mRNA vaccine induced stronger immune responses than did the homologous ChAdOx1 vaccine series, according to recent immunogenicity studies.
Alternative Titles
Full title
A ‘mix and match’ approach to SARS-CoV-2 vaccination
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2555640959
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2555640959
Other Identifiers
ISSN
1078-8956,1546-170X
E-ISSN
1546-170X
DOI
10.1038/s41591-021-01463-x
